Ring enhancement on T 1-weighted GRE images after ferucarbotran administration for hepatic metastasis: Comparison with pathological findings: Case report

Radiation Medicine - Medical Imaging and Radiation Oncology

Volumn 23, Issue 1, 2005, Pages 75-79

  Kitajima, Kazuhiro ^a   Kuwata, Yoichiro ^a   Hayashi, Masahiko ^a   Imanaka, Kazufumi ^a   Kaji, Yasushi ^b   Sugimura, Kazuro ^b  

^a NISHI KOBE MEDICAL CENTER   (Japan)

^b KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Hepatic metastasis; Magnetic resonance (MR) imaging; Peritumoral edema; Ring enhancement; Superparamagnetic iron oxide (SPIO)

Indexed keywords

FERUCARBOTRAN; GADOLINIUM PENTETATE; SH U 535A; SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG; CONTRAST MEDIUM; DIAGNOSTIC AGENT; IRON; OXIDE;

ADULT; ARTICLE; CANCER CELL; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; ECHOGRAPHY; ESOPHAGUS CARCINOMA; GRADIENT RECALLED ECHO IMAGE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMAGE ENHANCEMENT; IMAGING SYSTEM; LIVER METASTASIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; RADIOLOGICAL PARAMETERS; RING ENHANCEMENT; TISSUE NECROSIS; DIFFERENTIAL DIAGNOSIS; LIVER TUMOR; METASTASIS; MIDDLE AGED; PORTAL PHLEBOGRAPHY;

CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; GADOLINIUM DTPA; HUMANS; IRON; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OXIDES; PORTOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 15744382454     PISSN: 02882043     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Mergo PJ, Helmberger T, Nicolas AI, Ros PR. Ring enhancement in ultrasmall superpramagnetic iron oxide MR imaging: a potential new sign for characterization of liver lesions. AJR Am J Roentgenol, 166: 379-384, 1996.
2. Chen JH. Real enhancement or merely increased contrast? AJR Am J Roentgenol, 168: 279-280, 1997.
3. Tanimoto A. SPIO-enhanced MR imaging. Japanese Journal of Diagnostic Imaging, 23: 1044-1056, 2003.
4. Ferrucci JT, Leo J, Rigler lecture. MR imaging of the liver. AJR Am J Roentgenol, 147: 1103-1116, 1986.
5. Hahn PF, Stark DD, Ferrucci JT. Accumulation of iron oxide particles around liver metastases during MR imaging. Gastrointest Radiol, 17: 173-174, 1992.
6. Marchal G, Tshibwabwa-Tumba E, Verbeken E, Baert A, Lauweryns J. Influence of tumoral and peritumoral vascularization on the sonographic study. In Advances in hepatobiliary. (Ferrucci JT, Mathieu D eds.; Mosby, St. Louis), pp. 109-128, 1990.
7. Outwater E, Tomaszewski JE, Daly JM, Kressel HY. Hepatic colorectal metastases; correlation of MR imaging and pathologic appearance. Radiology, 180: 327-332, 1991.
8. Nakayama M, Yamashita Y, Mitsuzaki K, et al. Improved tissue characterization of focal liver lesions with ferumoxide-enhanced T1 and T2-weighted MR imaging. J Magn Reson Imaging, 11: 647-654, 2000.
9. Reimer P, Jahnke N, Fiebich M, et al. Hepatic lesion detection and characterization; value of nonenhanced MR imaging, superparamagnetic iron oxide-enhanced MR imaging, and spiral CT-ROC analysis. Radiology, 217: 152-158, 2000.
10. Denys A, Arrive L, Servois V, et al. Hepatic tumors; detection and characterization at 1-T MR imaging enhanced with AMI-25. Radiology, 193: 665-669, 1994.
11. Reimer P, Tombach B. Hepatic MRI with SPIO: detection and characterization of focal liver lesions. Eur Radiol, 8: 1198-1204, 1998.